Weight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
Ireland's pharmaceutical industry shipped billions' worth of goods to the U.S., but face threats from Trump 2.0.
Irish Examiner4d
Regional success story: US firms' nationwide boost for Irish economy
In total, 234 investments creating 13,500 new jobs over the next five years, 59% of which were in regional locations ...
Irish Examiner on MSN7d
Acquisition activity in Irish sciences sector shifts to smaller deals
Some 17 companies successfully raised growth capital totalling €503m. This equates to a 254% increase in value terms compared ...
Irish Examiner8d
Innovating beyond boundaries: Sarah O’Keeffe’s career in making medicine
Sarah O’Keeffe recounts her fulfilling career path with Eli Lilly from employee to Senior Vice President, Product Research ...
Nasdaq14d
What Are Wall Street Analysts' Target Price for Eli Lilly Stock?
With a market cap of $799.5 billion, Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading global pharmaceutical firm renowned for its innovative contributions to healthcare.
Yahoo Finance14d
Lilly reassures investors that weight-loss drug demand is strong, shares rise
(Reuters) -Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing investor agitation about signs of weakness in sales of the drugs.
Newsday14d
Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.